Atrial tachycardias (ATs) are a significant source of morbidity in adults with congenital heart disease (CHD). This study evaluates the incidence and clinical predictors of AT in a cohort of patients with CHD.
A trial tachycardias (ATs) are the most common long-term complication in adults with congenital heart disease (CHD) and a leading source of morbidity and hospital admissions. 1, 2 In addition, they have been related to increased mortality and sudden cardiac death. 3, 4 However, contemporary literature on the natural history and prognostic risk factors for long-term development of AT in adults with CHD is sparse. 5 Previous lesion-specific studies have highlighted the role of different factors such as age, underlying anatomic defect, surgical repair, postsurgical scars, or hemodynamic sequelae. [6] [7] [8] [9] [10] [11] [12] [13] Nevertheless, they are limited to specific diagnosis, although the adult CHD population is very heterogeneous, making these results difficult to extrapolate to the entire cohort of subjects with diverse congenital defects. On the other hand, population studies based on administrative data have provided epidemiological information about lifetime incidence of atrial arrhythmias and have emphasized the importance of age as a significant risk factor. Unfortunately, inherent limitations precluded discriminating between different atrial arrhythmias (ie, AT and atrial fibrillation [AF] ). Moreover, certain relevant clinical parameters were not assessed, as they were unavailable for analysis. 1 Therefore, the aim of this study was (1) to investigate the incidence and natural history of AT in a cohort of adult patients with CHD, (2) to explore potential risk factors for developing AT, and (3) to validate the findings in a separate cohort of patients.
WHAT IS KNOWN
• Atrial tachycardias (ATs) are a common long-term complication in adults with congenital heart disease, causing increased morbidity and mortality.
• Some risk factors for AT have been previously described in lesion-specific studies, but natural history in a whole cohort of congenital heart disease patients has not been well studied.
WHAT THE STUDY ADDS
• Natural history of AT differed widely among the most common forms of congenital heart disease.
• We provided 8 simple clinical parameters, easily obtained by noninvasive means, that are independent predictors of AT in adults with congenital heart disease, regardless the underlying diagnosis.
• Subjects without any of these risk factors had a very low risk of AT, although their addition progressively increased arrhythmia burden.
• These results were validated in an external cohort of patients.
METHODS

Study Cohort
A registry of all patients followed by the adult CHD Unit at La Paz University Hospital (Madrid, Spain) was begun in December 1989. Patients entered the study on the date of their first visit at the adult CHD Unit or on January 1, 1990, if they had been followed since before the registry start date. Outpatient follow-up was scheduled at the discretion of the treating physicians according to the underlying CHD, common clinical practice and recommendations.
14 By December 2013, the database contained the records of 3764 individuals. For the present study, CHD was defined according to previously described criteria 15 and complexity was categorized according to the Bethesda classification. 16 Patients were classified based on the major underlying defect, and those with combinations of lesions were assigned to the highest complexity group. Subjects were excluded if they were diagnosed with isolated patent foramen ovale, mitral valve prolapse, cardiac arrhythmias without structural abnormalities, nonischemic congenital coronary artery anomalies, abnormalities of the great veins (such as isolated persistent left superior vena cava) or of the branches of the aortic arch lacking functional repercussions, congenital cardiomyopathies, or Marfan syndrome (n=314). Patients with incomplete demographic information were also excluded (n=139).
Thus, a total of 3311 adults with CHD comprised the study cohort. The local research ethics committee approved the study.
Data Collection
Data on demographics, anatomy, surgical or percutaneous repairs and palliations, clinical status, and complications were prospectively entered and thoroughly updated by the senior investigator (J.M.O.). Details about 2-dimensional echocardiograms, cardiac magnetic resonance imaging, and cardiac catheterization were also collected. For the purposes of this study, moderate-to-severe systemic or pulmonary ventricular systolic dysfunction was qualitatively or quantitatively assessed by imaging techniques. Valvular dysfunction was graded as absent, mild, moderate, and severe from Doppler color flow mapping and continuous wave tracings. 17 Pulmonary outflow tract stenosis was defined as Doppler or catheter peak pressure gradient >50 mm Hg at valvular, subvalvular, or supravalvular level (or >30 mm Hg in the setting of severe pulmonary ventricular dysfunction) and aortic outflow tract stenosis as Doppler or catheter mean systolic pressure gradient >40 mm Hg. Severe pulmonary hypertension was assumed to exist when a maximum velocity of pulmonary atrioventricular (AV) valve regurgitation jet >3.5 m/s was measured by continuous Doppler in the absence of pulmonary stenosis. Cyanosis was defined as arterial oxygen saturation <90% caused by significant right-to-left shunting or clinical cyanosis. Data from the most recent tests preceding AT or the last available (in patients without AT) were used to perform the analysis.
Sustained clinical electrocardiographically documented arrhythmias occurring during follow-up, requiring pharmacological management, electric cardioversion, or catheter ablation, were included in the analysis. Atrial arrhythmias were classified as AT if regular atrial waves with constant cycle length were observed or AF in case of irregular atrial rhythm with clear beat-to-beat variation. For the purpose of this study, we focused on patients experiencing AT (with or without coexisting AF); thus, subjects with isolated AF were excluded from the analysis. No distinction was made between macroreentrant or focal tachycardias. Nonsustained episodes of AT during Holter monitoring or device interrogation and perioperative (first 30 days after surgery) arrhythmias were excluded.
Mortality data were obtained from clinical records and telephonic interviews when needed. In addition, the vital status of each patient at the end of the study (June 30, 2014) was further verified by cross-checking the available identifying information on all 3311 patients to the Spanish National Death Index. To avoid inaccuracies, the treating physicians with full knowledge of the patient's medical history collected all the follow-up data.
To assess the potential impact of changes in medical or surgical care throughout the study period, we divided the cohort into 2 different eras (1990-2001 and 2002-2013) according to the time of their first visit to the CHD Unit.
Statistical Analysis
Continuous variables were not normally distributed, so they are presented as median and first and third quartiles (Q1-Q3), and comparisons were made using the MannWhitney rank-sum test. Categorical variables are summarized as frequencies and percentages and were compared with the χ 2 test. Cumulative freedom from AT was estimated using lefttruncated and right-censored Kaplan-Meier curves considering age as time scale. Thus, individual survival times were calculated with the age at the inclusion in the database and the age at either the event or end of follow-up. Survival times and 95% confidence interval (CI) were generated using R programming language with survival library and comparisons between groups performed by 2-sample log-rank test. Patients without adverse events were treated as censored observations at closing date if they had been examined within the previous 2 years, or at the date of the last visit if they could not be contacted.
Hazard rates for AT by decade for each different major form of CHD were calculated by relating the number of new events to the person-years at risk during 10 years periods. To assess predictors of AT, univariable analysis of individual variables was performed using Cox proportional hazards models. Variables with a P <0.2 were entered in a multivariable analysis. The proportional hazards assumption was confirmed analyzing the Schoenfeld residuals. As the variable single ventricle physiology included all patients with Fontan surgery, both parameters were not included together in the same model. Likewise, because of significant interaction with other covariates, complexity was not included in the multivariable analysis. Time-dependent receiver operating characteristic (ROC) curves were used to assess the discriminative ability of the model obtained in the study cohort, and conventional ROC curves were used in the external cohort.
All tests were 2-tailed, and a P value <0.05 was considered statistically significant.
Analyses were performed with the IBM SPSS Statistics software version 20.0 (SPSS, Chicago, IL) and R software version 3.1.2 (available at https://www.r-project.org).
Validation Cohort
An external contemporary cohort of 1432 consecutive adult individuals prospectively followed up at the Intercenter CHD Unit (Hospital Virgen Macarena y Virgen del Rocío, Sevilla, Spain) was used to validate the risk factors obtained from the study cohort.
RESULTS
Study Cohort Characteristics
Baseline characteristics of the study cohort are summarized in Table 1 . We included 3311 patients (median age at first examination, 23 years; Q1-Q3, 18-39 years; 51% males) under follow-up at our institution (median, 11 years; Q1-Q3, 4-18 years; corresponding to a total of 37 607 person-years), covering the whole spectrum of CHD (Table I in the Data Supplement). According to complexity, 49% had simple, 39% moderate, and 12% severe defects. The most common diagnoses were left ventricular outflow tract obstructive lesions (n=681; 21%), ostium secundum or sinus venosus atrial septal defects (ASDs; n=439; 13%), ventricular septal defects (n=356; 11%), aortic coarctation (n=353; 11%), and tetralogy of Fallot (n=327; 10%). One hundred twenty-two patients had d-transposition of the great arteries (d-TGA; 4%), of whom 106 (87%) had undergone atrial switch repair. Also, 110 (3%) subjects had univentricular hearts including 51 with different forms of Fontan procedures. Demographic characteristics of subjects in both study eras (1990-2001 and 2002-2013) were well balanced (Table II in the Data Supplement).
Arrhythmia Burden
Overall, 296 (8.9%) subjects presented atrial arrhythmias (AT or AF), including 139 patients (4.2%) with AT only, 143 (4.3%) with AF only, and 14 (0.5%) who had both.
Among patients experiencing AT, the most common forms of CHD were tetralogy of Fallot (n=30; 19.6%), d-TGA (n=27; 17.6%), ostium secundum ASD (n=24; 15.7%), and univentricular hearts (n=23, 15%; Figure I in the Data Supplement). Most of them (n=131; 86%) had undergone previous intracardiac repair. AT burden was highest in single ventricles (22.8%) and d-TGA (22.1%), whereas tetralogy of Fallot was the CHD of moderate complexity with the highest AT incidence (9.2%) followed by Ebstein anomaly (7.9%; Figure 1 ).
Natural History
Cumulative freedom from AT at different ages in the whole cohort and according to disease complexity is displayed in Figure 2 . As expected, AT-free survival was lower in complex CHD compared with moderate and simple CHD (P<0.001). Moreover, the first episode of Repair in adulthood 743 (22) 262 (18) No intervention 1128 (34) 375 (26) Systemic right ventricle 170 (5) 77 (5) Single ventricle physiology 110 (3) 67 (5) Fontan procedure 51 (2) 53 (4) Severe pulmonary hypertension 150 (5) 99 (7) Chronic cyanosis 173 (5) 13 (1) Previous intracardiac repair 1837 (55) 859 (60) Pretricuspid L-R shunt 474 (14) 243 (17) Posttricuspid L-R shunt 587 (18) 206 (14) Significant LVOT obstruction 188 (6) AT occurred at a younger age in complex (median age, 27 years; Q1-Q3, 20-35 years) compared with moderate (41 years; Q1-Q3, 31-51 years) or simple (41 years; Q1-Q3, 29-55 years) defects (P<0.001 for both). Survival free from AT was similar in the early and late study periods ( Figure II in the Data Supplement).
Interestingly, as shown in Figure 3A and 3B, not only presentation age but also natural history and time lapse since surgery to occurrence of AT varied significantly among the most common CHD diagnoses. AT occurred at an earlier age in d-TGA and single ventricle physiology, with a median latency period of 23 and 16 years after surgery, respectively. AT hazard rate was highest in the third and fourth decades of life in these patients. On the other hand, AT hazard rate for ASD patients was highest in the fifth decade of life, and time between surgery and arrhythmia presentation was shorter than in more complex forms of CHD (median 12 years) owing in part to the fact that these patients underwent surgery later in life. Hazard rate of AT in patients with tetralogy of Fallot was highest over 40 years; consequently, the time interval between surgery and arrhythmia presentation was longer (median 32 years).
Clinical Predictors
Results from the univariable Cox regression analysis are presented in Table 2 . Individually, the strongest predictors associated with AT were Fontan procedure (hazard ratio [HR], 10.2; 95% CI, 5.5-18.9) and complex CHD (HR, 17; 95% CI, 9.4-31). After multivariable analysis, the independent predictors jointly associated with AT were univentricular physiology (HR, 13.2; 95% CI, 5.5-31.7), previous intracardiac repair (HR, 6.8; 95% CI, 3.4-13.5), systemic right ventricle (HR, 5; 95% CI, 2.6-9.6), severe pulmonary hypertension (HR, Figure 4B , ATfree survival declined as the number of risk factors in a subject increased.
External Validation
Demographic characteristics of the subjects from the external cohort are depicted in Table 1 . In summary, they were older (median age, 29 years; Q1-Q3, 22-41 years; P<0.001 compared with the study cohort) although with similar sex distribution (52% males, P=0.344). Also, they were more complex patients as only 34% had simple defects, whereas 47% had moderate and 19% had complex CHD (P<0.001 compared with the study cohort).
During a median follow-up of 5 years (Q1-Q3, 2-8 years; 5633 person-years), a total of 174 (12.2%) had atrial arrhythmias (AT or AF), including 86 (6%) with AT, 65 with AF (4.5%), and 23 (1.6%) who had both. At the end of follow-up, prevalence of both atrial arrhythmias was significantly higher compared with the study group (AT: 7.6% versus 4.6%, P<0.001; AF: 6% versus 4.7%, P=0.045).
Despite these differences, when the fitted model with 8 AT risk factors was applied to the validation cohort, it yielded an excellent discrimination power 
DISCUSSION Main Findings
To the best of our knowledge, this is the first study offering an overview of the natural history and risk factors associated with AT in a cohort of subjects with a wide variety of CHD and long follow-up at tertiary center. We provide data on AT-free survival at different life ages and present a risk stratification tool for AT based on 8 simple risk factors, easily obtained during outpatient visits by noninvasive means. Contrary to previous studies, information was entered in the database and updated periodically. Thus, patients were longitudinally followed until death or the closing date. These data sets are not easily found in the field of CHD.
Arrhythmia Burden and Natural History
As would be expected, AT burden was strikingly high in some forms of complex CHD, such as univentricular hearts (22.8%) and d-TGA (22.1%), whereas tetralogy of Fallot was the CHD of moderate complexity with the greatest AT incidence (9.2%).
It was not surprising that patients with more complex CHD were afflicted by these arrhythmias at younger ages than subjects with moderate or simple defects. Hazard rates of AT and age distribution differed remarkably among the most significant CHD. AT hazard rate was highest in the third and fourth decades of life in subjects with univentricular hearts and d-TGA, in the fifth decade in patients with tetralogy of Fallot and over the sixth decade in ASD patients. Time lapse since the main surgery to AT development also varied according to the underlying diagnoses. Specifically, AT developed after long periods of exposure to abnormal hemodynamic conditions, which may occur either after surgery in moderate (ie, tetralogy of Fallot) or complex (ie, d-TGA with atrial switch or univentricular hearts) CHD, or before correction in simple defects (ie, ASD; Figure 3 ).
These findings are consistent with but also further expand previous observations from both populationbased and lesion-specific studies. Bouchardy et al 1 reported substantial epidemiological information on lifetime risk of atrial arrhythmias and their impact on prognosis in patients with CHD in Quebec province (Canada). Nonetheless, as data collection was obtained from administrative codes based on the International Classification of Diseases, no distinction could be made between AT and AF, hampering specific analysis of both arrhythmias separately. Furthermore, information on important patient clinical parameters, such as ventricular function, was not available to the authors so predictors of arrhythmic burden could not be assessed. On the contrary, other studies have focused specifically on single diagnosis, including ASD, tetralogy of Fallot, d-TGA or individuals with Fontan procedure. [6] [7] [8] [9] [10] [11] [12] [13] Long-term survival can be estimated using standard survival analysis with age as time to event scale and accounting for left truncation and immortal persontime bias, as it provides more realistic survival estimates. By using this method, several researches have recently reported that survival of patients with CHD is worse compared with the expected survival of the general population and that there are substantial differences in life expectancy according to lesion complexity and specific heart defects. [18] [19] [20] [21] Cumulative freedom from AT data is hereby presented using this novel approach that allows reporting results at different life ages avoiding survival overestimation (Figure 2 ). This is relevant in a diverse population such as CHD where the relationship between age and event is widely variable across the different subgroups. In classical Kaplan-Meier curves, constructed with follow-up as time scale, age at the event is not considered and, thus, that meaningful information is lost.
Risk Stratification
We report simple clinical variables, namely univentricular physiology, previous intracardiac repair, systemic right ventricle, severe pulmonary hypertension, pulmonary regurgitation, pulmonary AV valve regurgitation, systemic and pulmonary ventricular dysfunction, that were independent risk factors jointly associated with AT in adults with CHD. They are easily obtained from the patient's baseline data or during regular follow-up visits by noninvasive means. This risk stratification tool may aid in identifying patients with either low or high risk of AT (Figure 4) .
In patients without any of these risk factors, freedom from AT was remarkably high. This is encouraging information that can offer reassurance to patients in such a clinical scenario. On the other hand, as the number of risk factors accumulated in a patient, ATfree survival progressively declined regardless of the underlying diagnosis. Consequently, an active search for AT (ie, Holter monitoring) should be pursued in the presence of palpitations and might even be justified in asymptomatic patients with numerous risk factors, strengthening current recommendations. 22 The role of these predictors was validated in a second contemporary cohort of patients with a higher number of complex CHD.
Mechanistic Insight
Not surprisingly, previous intracardiac surgery increased the risk of AT by 7-fold and emerged as an important arrhythmic predictor. Surgical scars, together with patch material and anatomic barriers (ie, valve annuli), form electric barriers that provide the perfect substrate for sustaining macroreentrant circuits, which is the main underlying arrhythmia mechanisms in these subjects. 23, 24 Also, many nonautomatic focal ATs arise from scar borders. 25 Despite surgical scars per se may promote atrial arrhythmias, 26 our results underpin the contribution of cardiac remodeling induced by the chronic volume and pressure overload typical of CHD patients. The role of increased mass, chamber distension, hypertrophy, and fibrosis is well recognized in the genesis of cardiac arrhythmias. 27, 28 Progressive atrial remodeling caused by persisting pressure/volume overload may be the cause of recurrent AT, even after successful treatment. 29 Persistent hemodynamic overload and remodeling are to be expected in the setting of ventricular dysfunction, significant right-sided valve regurgitation, pulmonary hypertension, systemic right ventricle and univentricular hearts, all of which were revealed as independent predictors of AT in our study. Macroreentrant circuits or AT foci, particularly in the CHD population, are typically located in the right atrium, 23, 24, [29] [30] [31] which likely explains why only right (but not left)-sided valve dysfunction emerged in the multivariable analysis, whereas left-sided valve sequelae would be more likely related to AF. 6, 32, 33 Although speculative, one can conceive that treating or correcting these sequelae could have a protective effect on the development of AT which may outweigh the proarrhythmic effects of additional surgical scars. Previous experience has shown that early interventions have a major impact in reducing atrial arrhythmias by preventing further cardiac remodeling. 7 Furthermore, AT often precedes AF onset in subjects with CHD so preventing AT may potentially delay the development of AF in some patients. 33 Likewise, surgical or catheter ablation at the time of sequelae correction and modification of surgical techniques to this end may be helpful in this context.
34-37
Limitations
Some limitations of our study must be noted. First, we present a series of patients followed in a tertiary referral center; therefore, our cohort and the case mix of specific forms of CHD may not represent those encountered in less specialized centers. In addition, more complex forms of CHD (ie, Fontan or d-TGA) are less well represented in our cohort, which may limit the validity of our results in these groups of patients. Second, although the subjects were systematically entered in the database and prospectively followed, it was not designed specifically with the aim of studying the incidence and predictors of atrial arrhythmias. Thus, some potential risk factors may have not been recorded and thus identified as such. For instance, information about medications or atrial size was not systematically collected, accordingly we were unable to assess their role in the burden of AT. Nonetheless, as discussed above, atrial enlargement is usually the consequence of hemodynamic sequelae such as AV valve regurgitation and/or ventricular dysfunction, which were strong predictors of AT in our cohort. Moreover, even if that information were available, it would be difficult to elucidate the specific role of each factor individually because of their robust association.
Third, nonsustained or short, paroxysmal, asymptomatic episodes of AT may have been undetected or, if noticed, not registered in the database during followup. Thus, their potential clinical implications have not been studied. Fourth, the number of AT episodes is relatively small in comparison with the overall cohort. Despite our results were confirmed in a validation cohort, further prospective studies, preferably multicentric, are warranted to better understand the natural history of AT and to determine the clinical usefulness of these predictors in CHD patients.
Fifth, this study spans close to 25 years of follow-up during which management of patients with CHD has continuously evolved. To study assess the influence of evolving therapies, the cohort was divided into 2 study periods. No differences were found in survival free from AT in both periods. Besides, as reflected by our findings, AT tended to occur 20 to 30 years after the main cardiac surgery. Thus, studies aimed at assessing the effects on atrial arrhythmia burden of improvements in surgical techniques will likely require longer follow-up.
Finally, validation was performed in an external cohort for whom the time course of AT was unknown, as such, the external validity of our risk stratification scheme was estimated for AT prevalence, rather than incidence.
Conclusions
The current report confirms that adults with CHD continue to be afflicted by atrial arrhythmias and that the highest AT incidence was observed in complex CHD and tetralogy of Fallot. Age at presentation, AT hazard rates and time lapse from surgery to the first AT episode varied widely across the most common forms of CHD.
Simple clinical parameters, namely univentricular physiology, previous intracardiac repair, systemic right ventricle, severe pulmonary hypertension, pulmonary regurgitation, pulmonary AV valve regurgitation, systemic and pulmonary ventricular dysfunction, were independent predictors for AT in adults with CHD. Although the risk of developing these arrhythmias was negligible in patients without any of these factors, their addition progressively increased arrhythmia burden. Although further studies are warranted to investigate if prevention and control of modifiable risk factors for AT could favorably impact long-term arrhythmia incidence, our data may help to move to a more comprehensive assessment of AT risk in adults with CHD. 
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